Fasiglifam, TAK-875

Ainm Ceimigeach:

(S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-il)methoxy)-2,3 -dihydrobenzofuran-3-yl) acetic acid

Còd SMILES:

O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3 )=CC=C12

Còd InChi:

InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21( 14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16, 23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1

iuchair InChi:

BZCALJIHZVNMGJ-HSZRJFAPSA-N

Facal-luirg:

1000413-72-8 ； CAS: 1000413-72-8 ； CAS: 1000413-72-8 ；TAK875；TAK-875；TAK 875；Fasiglifam

Solubility:Soluble ann an DMSO, chan ann ann an uisge

Stòradh:0 - 4 C airson geàrr-ùine (làithean gu seachdainean), no -20 C airson ùine fhada (mìosan).

Tuairisgeul:

Tha Fasilifam (TAK-875) na agonist GPR40 èifeachdach, beòil agus roghnach.

Targaid: GPR40 agonist